Riluzole Tablet, Film Coated
Product Images NDC 42291-775

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Riluzole (NDC 42291-775). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

50 (775 60 50mg)

Packaging label for Riluzole Tablets, USP 50 mg by AvKARE. The label indicates the product contains 60 film-coated tablets for oral use, with storage instructions and a barcode visible. It is marked as prescription only and includes the AvKARE logo and NDC information.*

FDA Label Image

Chemical-structure-riluzole (Spl Image 1 Structure)

Chemical structure of riluzole, showing the arrangement of atoms including nitrogen, sulfur, fluorine, and oxygen in the molecule.*

FDA Label Image

Figure1 (Spl Image 2 Figure 1)

A Kaplan-Meier survival curve graph comparing survival probabilities over time in months for two groups: one receiving Riluzole 50 mg twice daily (N=77) and one receiving placebo (N=78). The vertical axis represents survival probability, and the horizontal axis represents months up to 21.*

FDA Label Image

Figure2 (Spl Image 3 Figure 2)

Kaplan-Meier survival curves comparing survival probability over time in months between two groups: Riluzole 50 mg twice daily (N=236) and placebo (N=242). The graph shows a higher survival probability for the Riluzole group across the observed period, up to 21 months.*

FDA Label Image

Table1 (Table1)

A data table comparing the incidence of adverse events between Riluzole Tablets 50 mg taken twice daily (N=313) and placebo (N=320). The table lists specific side effects such as asthenia, nausea, decreased lung function, and hypertension, with corresponding percentage values for each group.*

FDA Label Image

Table2 (Table2)

A data table titled 'Pharmacokinetic Parameters of Riluzole' presenting information on absorption, distribution, elimination, metabolism, and excretion. It includes bioavailability, dose proportionality, food effect, plasma protein binding, elimination half-life, metabolic pathways, active metabolites, and elimination routes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.